Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers

PURPOSE: Tumor-derived cell-free DNA (cfDNA) from urine of patients with cancer offers non-invasive biologic material for detection of cancer-related molecular abnormalities such as mutations in Exon 2 of KRAS. EXPERIMENTAL DESIGN: A quantitative, mutation-enrichment next-generation sequencing test...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Clin Cancer Res
Main Authors: Fujii, Takeo, Barzi, Afsaneh, Sartore-Bianchi, Andrea, Cassingena, Andrea, Siravegna, Giulia, Karp, Daniel D., Piha-Paul, Sarina A., Subbiah, Vivek, Tsimberidou, Apostolia M., Huang, Helen J., Veronese, Silvio, Di Nicolantonio, Federica, Pingle, Sandeep, Vibat, Cecile Rose T., Hancock, Saege, Berz, David, Melnikova, Vladislava O., Erlander, Mark G., Luthra, Rajyalakshmi, Kopetz, E. Scott, Meric-Bernstam, Funda, Siena, Salvatore, Lenz, Heinz-Joseph, Bardelli, Alberto, Janku, Filip
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2017
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5511562/
https://ncbi.nlm.nih.gov/pubmed/28096270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-2592
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla